Publications by authors named "Peter Sondermann"

Claim this Profile
D
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
Marta Lustig, Chilam Chan, J H Marco Jansen, Maria Bräutigam, Max A Kölling, Peter Sondermann

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FcγRIIIa chromatography to enrich a-fucosylated glycoforms and assess the potency of glycoengineered therapeutic antibodies.
Anne Freimoser-Grundschober, Petra Rueger, Felix Fingas, Peter Sondermann, Sylvia Herter

J Chromatogr A· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Autoantibody-Induced Pathology.
Ralf J Ludwig, Karen Vanhoorelbeke, Frank Leypoldt, Ziya Kaya, Katja Bieber, Peter Sondermann

Front Immunol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing Fc receptor biology in the design of therapeutic antibodies.
Peter Sondermann, David E Szymkowski

Curr Opin Immunol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FcγR/IgG Interaction as Target for the Treatment of Autoimmune Diseases.
Peter Sondermann

J Clin Immunol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo.
Stefan Lohse, Saskia Meyer, Laura A P M Meulenbroek, J H Marco Jansen, Maaike Nederend, Peter Sondermann

Cancer Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita.
Hiroaki Iwata, Elena Pipi, Nicole Möckel, Peter Sondermann, Artem Vorobyev

J Invest Dermatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated Fc.
Peter Sondermann, Andrew Pincetic, Jad Maamary, Katja Lammens, Jeffrey V Ravetch

Proc Natl Acad Sci U S A· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General mechanism for modulating immunoglobulin effector function.
Peter Sondermann, Andrew Pincetic, Jad Maamary, Katja Lammens, Jeffrey V Ravetch

Proc Natl Acad Sci U S A· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
Claudia Ferrara, Sandra Grau, Christiane Jäger, Peter Sondermann, Peter Brünker

Proc Natl Acad Sci U S A· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies.
Alfred Schnueriger, Roger Grau, Peter Sondermann, Thomas Schreitmueller, Stefan Marti

Mol Immunol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity.
Ekkehard Mössner, Peter Brünker, Samuel Moser, Ursula Püntener, Carla Schmidt, Peter Sondermann

Blood· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amelioration of collagen-induced arthritis by human recombinant soluble FcgammaRIIb.
Sofia E Magnusson, Maria Andrén, Kajsa E Nilsson, Peter Sondermann, Uwe Jacob

Clin Immunol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms.
Claudia Ferrara, Fiona Stuart, Peter Sondermann, Peter Brünker, Pablo Umaña

J Biol Chem· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG.
Katja Wenig, Lorenz Chatwell, Ulrich von Pawel-Rammingen, Lars Björck, Robert Huber, Peter Sondermann

Proc Natl Acad Sci U S A· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the stoichiometry of protein complexes using liquid chromatography with fluorescence and mass spectrometric detection of fluorescently labeled proteolytic peptides.
Elisabeth O Hochleitner, Peter Sondermann, Friedrich Lottspeich

Proteomics· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Purification, crystallization and X-ray diffraction analysis of the extracellular part of the human Fc receptor for IgA, FcalphaRI (CD89).
Katja Wenig, Peter Sondermann

Acta Crystallogr D Biol Crystallogr· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The structure of Fc receptor/Ig complexes: considerations on stoichiometry and potential inhibitors.
Peter Sondermann, Vaughan Oosthuizen

Immunol Lett· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis